Mandate

Vinge advises Smart Eye in connection with a directed issue of new shares

September 19, 2018 Capital Markets and Public M&A

Vinge has advised Smart Eye AB (publ) in connection with a directed issue of new shares to institutional investors as a result of which Swedbank Robur Ny Teknik will become a significant owner with 7.6% of the votes and capital.

The subscription price, i.e. SEK 52 per share, has been determined through a so called accelerated book building process. As a result of new share issue, Smart Eye has acquired approximately MSEK 114. Carnegie Investment Bank acted as financial adviser and sole book runner.

Vinge’s team primarily consisted of Anders Strid, Wibeke Sorling and company registration assistant Camilla Andersson.
 

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024